These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 12610256)
1. Cultural competence and corporate culture. Wertman M Psychiatr Serv; 2003 Mar; 54(3):403-4; author reply 404. PubMed ID: 12610256 [No Abstract] [Full Text] [Related]
2. AstraZeneca pays $520m fine for off label marketing. Tanne JH BMJ; 2010 Apr; 340():c2380. PubMed ID: 20430836 [No Abstract] [Full Text] [Related]
3. Co-opting psychiatry: the alliance between academic psychiatry and the pharmaceutical industry. Moncrieff J Epidemiol Psichiatr Soc; 2007; 16(3):192-6. PubMed ID: 18020190 [TBL] [Abstract][Full Text] [Related]
4. [Are appearances deceptive? Evidence-based instead of marketing-based psychiatry]. Sommer IE; Hoencamp E; Spijker J; Kupka RW; Beekman AT; de Haan L Tijdschr Psychiatr; 2016; 58(2):154-6. PubMed ID: 26881351 [No Abstract] [Full Text] [Related]
5. Marketing of antipsychotic drugs targeted doctors of Medicaid patients, report says. Roehr B BMJ; 2012 Oct; 345():e6633. PubMed ID: 23033376 [No Abstract] [Full Text] [Related]
6. Industry funding and author-industry affiliation in clinical trials in psychiatry. Montgomery JH Am J Psychiatry; 2006 Jun; 163(6):1110-1; author reply 1111. PubMed ID: 16741218 [No Abstract] [Full Text] [Related]
7. Use of prescription psychiatric drugs and religious service attendance. Harris KM; Larson S; Edlund MJ Psychiatr Serv; 2005 Apr; 56(4):396. PubMed ID: 15812085 [No Abstract] [Full Text] [Related]
8. Quetiapine use: science or clever marketing? Monasterio E; McKean A Aust N Z J Psychiatry; 2013 Jan; 47(1):96-7. PubMed ID: 22802551 [No Abstract] [Full Text] [Related]
9. [Clinical trials in psychiatry: present status and prospects]. Azorin JM; Belzeaux R; Adida M Encephale; 2016 Dec; 42(6S):S1. PubMed ID: 28236985 [No Abstract] [Full Text] [Related]
10. On the road. The Lancet Psychiatry Lancet Psychiatry; 2015 Aug; 2(8):667. PubMed ID: 26249277 [No Abstract] [Full Text] [Related]
11. [Evaluation of psychopharmacotherapy in elderly patients in different psychiatric settings]. Rotshteĭn VG; Saforova TP; Sheshenin VS; Fedorov VV; Bogdan MN; Suetin ME Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(2):59-65. PubMed ID: 23528585 [No Abstract] [Full Text] [Related]
12. Clinical efficacy data on gene tests trails marketing in psychiatry. Dolgin E Nat Med; 2012 Aug; 18(8):1161. PubMed ID: 22869173 [No Abstract] [Full Text] [Related]
13. Drug company representatives and psychiatrists. Christensen RC; Garces LK Psychiatr Serv; 2004 Aug; 55(8):944. PubMed ID: 15292550 [No Abstract] [Full Text] [Related]
15. Organizational ethics and the high cost of medicines. Candilis PJ HEC Forum; 2000 Dec; 12(4):303-10. PubMed ID: 11138249 [No Abstract] [Full Text] [Related]
16. The introduction of chlorpromazine in Belgium and the Netherlands (1951-1968); tango between old and new treatment features. Pieters T; Majerus B Stud Hist Philos Biol Biomed Sci; 2011 Dec; 42(4):443-52. PubMed ID: 22035718 [TBL] [Abstract][Full Text] [Related]
17. Should psychiatrists lie to access suitable treatment for their patients? Drew L Australas Psychiatry; 2004 Mar; 12(1):82. PubMed ID: 15715748 [No Abstract] [Full Text] [Related]
18. The definition of a psychiatrist. Langsley DG; Hollender MH Am J Psychiatry; 1982 Jan; 139(1):81-5. PubMed ID: 7055280 [No Abstract] [Full Text] [Related]
19. Commentary: purchasing community perspective. Moore MC J Clin Psychiatry; 2003; 64 Suppl 17():33-4. PubMed ID: 14680426 [No Abstract] [Full Text] [Related]
20. Comparison of schizophrenia drugs often favors firm funding study. Vendantam S Washington Post; 2006 Apr; ():A1, A6. PubMed ID: 16856276 [No Abstract] [Full Text] [Related] [Next] [New Search]